Originally published In Press as doi:10.1074/jbc.M002546200 on May 2, 2000
J. Biol. Chem., Vol. 275, Issue 30, 23219-23226, July 28, 2000
The Major Head Protein of Bacteriophage T4 Binds Specifically to
Elongation Factor Tu*
Ryan
Bingham
,
Stephen I. N.
Ekunwe§,
Sherry
Falk§,
Larry
Snyder§¶, and
Colin
Kleanthous
¶
From the
School of Biological Sciences, University of
East Anglia, Norwich NR4 7TJ, United Kingdom and the
§ Department of Microbiology, Michigan State University,
East Lansing, Michigan 48824
Received for publication, March 26, 2000, and in revised form, April 27, 2000
 |
ABSTRACT |
The Lit protease in Escherichia coli
K-12 strains induces cell death in response to bacteriophage T4
infection by cleaving translation elongation factor (EF) Tu and
shutting down translation. Suicide of the cell is timed to the
appearance late in the maturation of the phage of a short peptide
sequence in the major head protein, the Gol peptide, which activates
proteolysis. In the present work we demonstrate that the Gol peptide
binds specifically to domains II and III of EF-Tu, creating the unique
substrate for the Lit protease, which then cleaves domain I, the
guanine nucleotide binding domain. The conformation of EF-Tu is
important for binding and Lit cleavage, because both are sensitive to
the identity of the bound nucleotide, with GDP being preferred over
GTP. We propose that association of the T4 coat protein with EF-Tu
plays a role in phage head assembly but that this association marks
infected cells for suicide when Lit is present. Based on these data and recent observations on human immunodeficiency virus type 1 maturation, we speculate that associations between host translation factors and
coat proteins may be integral to viral assembly in both prokaryotes and eukaryotes.
 |
INTRODUCTION |
Elongation factor (EF)1
Tu is the major host translation factor in Escherichia coli
responsible for delivering charged tRNAs to the ribosome for protein
synthesis. During its role in translation, EF-Tu interacts with a
number of molecules, including the nucleotides GTP and GDP,
aminoacylated tRNA molecules, mRNA-programmed ribosomes, and the
nucleotide exchange factor EF-Ts (1). In addition to forming complexes
with these molecules, EF-Tu is also known to serve as one of the
subunits in the bacteriophage Q
replicase (2) and has recently been
shown to have chaperone-like activity in vitro, promoting
the renaturation of some denatured proteins (3). Hence, EF-Tu is
capable of interacting with a variety of macromolecules and serving
more than one biological function. In addition to these associations,
EF-Tu also undergoes post-translation modifications, including
methylation at a specific lysine residue, which appears to attenuate
its GTPase activity and is linked to the growth phase of the cells (4),
and phosphorylation, although the physiological role of this
modification is uncertain (5).
EF-Tu is also the target of a bacteriophage exclusion system (6).
Bacteriophage exclusion is a defense mechanism in which bacteria commit
altruistic suicide in response to infection, thereby preventing
propagation of the phage (7, 8). Although distinct to apoptosis in
eukaryotes, similarities have been drawn between this form of suicide
and programmed cell death events in multicellular organisms (9).
Generally, these exclusion systems are mediated by the action of one or
more nonessential proteins encoded by prophages, plasmids, or
transposons. One of the best studied is that of E. coli K-12
strains, which exclude T4 bacteriophage as well as other T-even phages
through the action of a metalloprotease called Lit (Late
Inhibitor of T4), encoded by the defective
prophage e14 (10). Following T4 phage infection of a Lit-containing
cell, EF-Tu is specifically cleaved by Lit between Gly59
and Ile60 in the RGITI motif of the effector I region
resulting in the inhibition of translation (6). This region, which is
involved in co-ordinating the
-phosphate of GTP as well as the bound
magnesium ion (11 and references cited therein), is conserved in other
translation elongation factors such as EF-G and common to the
homologous eukaryotic translation factors EF-1
and EF-2. The fact
that neither EF-G nor heat-inactivated EF-Tu are cleaved by Lit
suggests that the three-dimensional structure of EF-Tu, and not just
the primary sequence of the proteolysis site, is required for cleavage
and that the cleavage reaction is highly specific, implying the
involvement of other regions of the translation factor (12).
Proteolysis of EF-Tu by Lit is activated by the appearance in the cell
of a short peptide determinant approximately 29 amino acids long,
beginning about 100 amino acids in from the N terminus of the
unprocessed major head protein of the infecting T-even phage, gp23 (56 kDa). This short peptide sequence was named the Gol peptide sequence,
because it was first identified by mutations in gp23 that allow the
phage to Grow On Lit-producing
bacteria (13). The Gol peptide sequence is highly conserved in the head protein of all T-even phages that have been characterized (14). It has
been possible to reproduce the entire phage exclusion system in a
purified three-component system containing EF-Tu, Lit protease, and a
chemically synthesized 29-amino acid peptide representing the minimal
gol region sequence. In this system, Lit-mediated cleavage
of the Gly59-Ile60 bond of EF-Tu is dependent
on the addition of the Gol peptide, with no additional viral or
bacterial proteins being required (12).
The absolute dependence for proteolysis on the Gol peptide in the
purified system raises the question of how the activation occurs. Few
peptide-activated proteases have been described in the literature,
although a well known example occurs in the maturation of adenovirus in
which an 11-residue C-terminal peptide of the viral coat protein
activates the thiol protease Ad2 through thiol-disulfide exchange to
cleave the same coat protein (15). In contrast, the Gol peptide acts in
trans, and, although the peptide contains a single cysteine,
this residue is not required for activation of Lit-mediated cleavage of
EF-Tu, indicating a mechanism distinct to that of Ad2 (12).
Here we report the results of a number of different experimental
approaches to show that the phage-derived Gol peptide binds to EF-Tu.
We also show that this complex forms an activated substrate for Lit and
that this association is sensitive to the identity of the nucleotide
bound to the translation factor. Because the association of viral
capsid proteins with host translation factors has also been
demonstrated in eukaryotic systems, we discuss how this type of
association may be a hitherto unrecognized requirement in the viral
infection of prokaryotic and eukaryotic cells.
 |
EXPERIMENTAL PROCEDURES |
Glutathione-Sepharose 4B Redipack columns were purchased from
Amersham Pharmacia Biotech. Vydac C8 and C18 reverse-phase columns were
from Phenomenex, and high pressure liquid chromatography (HPLC)
reagents, such as HPLC-grade water, acetonitrile, and trifluoroacetic acid, were from Pierce. Tritiated N-ethylmaleimide
([3H]NEM; 40-60 Ci/mmol) and [
32P]GTP
(>5000 Ci/mmol) were from NEN Life Science Products and Amersham
Pharmacia Biotech, respectively.
1-Ethyl-3-(3-dimethylaminopropyl)carbodi-imide hydrochloride (EDC),
GDP, GTP, and guanosine 5'-o-(3-thiotriphosphate) were
obtained from Sigma. Both E. coli Lit and EF-Tu were
prepared as described previously (16, 12). Synthetic Gol peptide was prepared chemically by either Affiniti Research Products Ltd. or Chiron
Inc. and HPLC-purified to 95% purity. N-terminal peptide sequencing
was performed by Alta Bioscience (University of Birmingham, UK) on an
Applied Biosystems 473A gas phase sequencer.
Construction of the Gol Peptide S-Tag Fusion--
The plasmid,
pET30PZ1, which was used to synthesize Gol peptide in vivo,
contains a 160-base pair PZ1 fragment extending from the natural
PstI site in the T4 gp23 gene to an
HindIII linker inserted at the end point of the
1
deletion downstream of the gol region (17) and then ligated
into the PstI and HindIII sites of pET30b
(Novagen). Once induced, the construct directs the synthesis of a
12-kDa polypeptide containing the gol region from gp23 close to the C terminus and an S-Tag at the N terminus. Overexpression of
active Gol peptide was confirmed by its inability to transform E. coli cells containing Lit and by the in vitro
activation of EF-Tu cleavage by Lit.
Lit-mediated EF-Tu Cleavage Assays--
The concentrations of
Lit, EF-Tu·GDP (or EF-Tu·GTP) and Gol peptide in the cleavage
assays were generally 0.2, 2, and 5 µM, respectively, in
a buffer containing 50 mM Tris-HCl, pH 8.0, 10 mM
-mercaptoethanol, 2 mM MgCl2,
and 10 µM GDP (or 10 µM guanosine 5'-o-(3-thiotriphosphate)). All reactions were generally
incubated at 30 °C for up to 60 min. The reactions were initiated by
the addition of Gol peptide and stopped by the addition of EDTA to a
final concentration of 10 mM. The reaction products were
analyzed by 10% SDS-polyacrylamide gel electrophoresis (PAGE), and
EF-Tu cleavage was quantified by densitometry using a Bio-Rad GS690 imaging densitometer. The rates of EF-Tu cleavage were determined as a
percentage of the starting EF-Tu using the software Multi-Analyst (Bio-Rad).
GSH Affinity Chromatography--
Cell extracts containing either
the S-Tagged Gol peptide or the GST-EF-Tu fusion protein were prepared
separately from E. coli JM109DE3/pET30PZ1 or
DH5/pGEX2T-tufA (18), respectively. Cultures (200 ml) were
grown at 37 °C to an A625 nm of 0.4 before
being transferred to 23 °C for 30 min where protein expression was
induced by the addition of
isopropyl-1-thio-
-D-galactopyranoside to a final
concentration of 0.1 mM. The cultures were then grown for a
further 3 h at 23 °C before being harvested by centrifugation. Preparation of the cell extracts prior to loading onto the glutathione column involved the resuspension of the cell pellets in 5 ml of 50 mM Tris, pH 7.5, 150 mM KCl, 5 mM
MgCl2 followed by sonication and finally centrifugation at
25,000 × g for 30 min to remove any particulate matter.
To detect interactions between the Gol peptide-S-Tag and GST-EF-Tu
fusion proteins, the extracts were mixed and incubated at 30 °C for
30 min. The combined extracts were filtered through a 0.45-µm Gelman
filter prior to layering onto a 2.5-ml glutathione Redipack column.
Following application, the column was washed with 3 volumes of the
above buffer before the retained proteins were eluted from the column
with reduced glutathione according to the manufacturer's instructions.
Fractions were collected and assayed for the Gol peptide-S-Tag fusion
protein by spotting 3 µl on a nitrocellulose filter and developing
the filter with an S-Tag detection kit (Novagen). Elution of the
GST-EF-Tu fusion protein was monitored by 10% SDS-PAGE.
EDC Cross-linking--
All cross-linking reactions were
performed in 50 mM MOPS, pH 7.9, 2 mM
MgCl2, 10 µM GDP (or 10 µM
guanosine 5'-o-(3-thiotriphosphate)) and generally contained
2 µM EF-Tu with a 100-fold excess of Gol peptide. EF-Tu
and Gol peptide were mixed and incubated at 18 °C for 30 min before
the addition of EDC to a final concentration of 2.5 mM. The
reactions were then incubated at 18 °C for an additional amount of
time, as described in the figure legend, prior to their quenching by
the addition of Tris-HCl, pH 8.0, to 100 mM final concentration. The samples were analyzed by 10% SDS-PAGE.
To remove excess Gol peptide from the cross-linking reactions for
analytical purposes, the samples were gel-filtered on an Amersham
Pharmacia Biotech S75 column (26 × 300 mm) equilibrated in 50 mM Tris-HCl, pH 8.0, 10 mM
-mercaptoethanol,
2 mM MgCl2, 10 µM GDP at 1 ml/min.
Tritiation of the Gol Peptide--
The Gol peptide
(1AVMGMVRRAIPNLIAFDICGVQPMNSPTG29),
corresponding to residues 93-122 of the full-length gp23 protein,
contains a single cysteine residue (Cys19). This can be
modified with [3H]NEM to yield tritiated peptide
([3H]Gol) unaffected in its ability to activate EF-Tu
cleavage and cross-link to EF-Tu. At a concentration of 1 mM, in 25 mM
Na2B4O7-HCl, pH 8.6, the Gol
peptide was incubated with 20 mM [3H]NEM
(0.0125 mCi/µmol NEM) for 5 h at 37 °C. The labeled peptide was separated from excess [3H]NEM by gel-filtration on an
Amersham Pharmacia Biotech S75 column (26 × 300 mm) equilibrated
in water at a flow rate of 1 ml/min. Fractions containing
[3H]Gol were pooled, lyophilized, and reconstituted into
1 ml of 50 mM MOPS, pH 7.9. The concentration and, hence,
the specific activity of the peptide (15.8 µCi/µmol peptide) were
determined. The efficiency of radiolabeling was estimated using
5,5'-dithio-bis(2-nitrobenzoic acid) to quantify the amount of
unmodified cysteine residues (19). Generally, the Gol peptide was
greater than 80% labeled.
Tryptic Digests--
Cross-linking reactions between the
tritiated Gol peptide and EF-Tu and all the relevant controls
(i.e. [3H]Gol and EF-Tu alone) were performed
as described previously except that the radiolabeled peptide was in a
20-fold molar excess to that of EF-Tu. Following gel-filtration of the
cross-linked complex to remove excess peptide, appropriate fractions
containing both radioactivity and EF-Tu were pooled and concentrated
using an Amicon Centricon 10 microconcentrator. The specific activity of the [3H]Gol·EF-Tu complex was determined (5.9 nCi/nmol complex). This material was then proteolytically digested by
the addition of 2% trypsin followed by incubation at 37 °C for
2 h. The proteolysis of bacterial EF-Tu by trypsin has been
reported from a number of laboratories (20, 21). The conditions used in
our study were similar to these and ensured the complete digestion of
EF-Tu and the generation of small peptide fragments. The digestions were stopped by the addition of soya bean trypsin inhibitor to a 4-fold
molar excess of that of trypsin. Control reactions were also treated in
a similar manner. The samples were analyzed by 10% SDS-PAGE and
reverse-phase HPLC.
Peptide Mapping by HPLC--
Peptides generated by trypsin
digestion were HPLC-purified on a Vydac C8 reverse-phase column that
had been equilibrated in 90% water/10% acetonitrile containing 0.1%
trifluoroacetic acid. The column was developed using a gradient up to
65% of 0.1% trifluoroacetic acid in 95% acetonitrile/5% water at a
flow rate of 1 ml/min over 35 min. For the digestion and separation of
the [3H]Gol·EF-Tu complex, three regions of the peptide
map, at retention times 16.5, 18.5, and 20 min, respectively, were
collected (pools A, B, and C) and rechromatographed on a Vydac C18
reverse-phase column equilibrated with 85% water/15% acetonitrile
containing 0.1% trifluoroacetic acid. The column was developed with a
gradient up to 30% of 0.1% trifluoroacetic acid in 95%
acetonitrile/5% water at a flow rate of 1 ml/min over 35 min. Single
radioactive peaks from all three pools were collected, lyophilized, and
submitted for N-terminal sequencing. For all HPLC steps, the recovery
of applied radioactivity was greater than 95%, and both the C8 and C18
columns were run at 18 °C while monitoring the absorbance at
220 nm.
Conversion of EF-Tu·GDP into EF-Tu·GTP--
To convert the
EF-Tu·GDP form into EF-Tu·GTP, 20 µM EF-Tu·GDP was
incubated with 200 µM guanosine
5'-o-(3-thiotriphosphate), 200 µM
phosphenolpyruvate, and 0.05 µg/µl pyruvate kinase for 30 min at
37 °C, essentially as described by Fasano et al. (22). The reaction was quenched on ice.
EF-Tu GTPase Assays--
Determination of the intrinsic GTPase
activity of EF-Tu was based upon the measurement of
-32P
liberated from [
-32P]GTP upon its hydrolysis as
described by Mesters et al. (23). All assays were carried
out in 64 mM Tris-HCl, pH 7.6, 80 mM
NH4Cl, 10 mM MgCl2, 10 mM
-mercaptoethanol, 83 µM
phosphenolpyruvate, 17 µg/ml pyruvate kinase, 1 µM
EF-Tu, and Gol peptide as indicated in the figure legend. For the rate
experiments, a 270-µl solution containing EF-Tu·GDP,
phosphenolpyruvate, pyruvate kinase, and 500 µM Gol
peptide was preincubated at 37 °C for 30 min. Then, [
-32P]GTP (1200 dpm/pmol), also preincubated with
phosphenolpyruvate and pyruvate kinase, was added to give a final
volume of 300 µl and a final concentration of
[
-32P]GTP of 5 µM. Aliquots of 30 µl
were removed from the reaction at the times indicated in the figure
legend and quenched by the addition of silicotungstate in 1 mM H2SO4 to a final concentration of 3.7 mM. Following the addition of ammonium molybdate in
2 M H2SO4 to a final concentration
of 0.74% (w/v), the liberated
-32P, as a
dodecamolybdate complex, was extracted into a 1:1 toluene/butan-2-ol mixture (24) and counted on a scintillation counter. For the titration
experiments, the concentration of Gol peptide in separate 30-µl
reactions was increased as indicated in the figure legend. The
reactions were then preincubated at 37 °C for 30 min before the
addition of [
-32P]GTP, then they were incubated for a
further 60 min before being quenched and analyzed as described above.
 |
RESULTS |
Detection of Gol Peptide-EF-Tu Complexes by Affinity
Chromatography--
To monitor the association of EF-Tu with Gol
peptide, separate extracts were prepared of bacterial cells containing
a glutathione S-transferase-EF-Tu (GST-EF-Tu) fusion protein
and a Gol peptide-S-Tag fusion (see "Experimental Procedures"). In
this construct, a 60-amino acid peptide of the gp23 protein that
spanned the Gol region was fused to an S-Tag. The extracts were mixed
and loaded onto a glutathione-Sepharose column. Fig.
1A shows that the GST-EF-Tu
fusion protein bound to the column along with some of the Gol
peptide-S-Tag fusion, which could then be eluted when the GST-EF-Tu
fusion protein was stripped from the column by the addition of excess
glutathione to the wash buffer (lanes d, e, and
f). Much less S-Tagged peptide was retained in identical
control experiments in which the S-Tag was not fused to the Gol
sequence (Fig. 1B) or if the GST protein was not fused to
EF-Tu (Fig. 1C). These data demonstrate that the peptide was
retained on the column due to a direct interaction between the Gol
peptide and EF-Tu rather than through nonspecific interactions between,
for example, GST and the S-Tag. Overall, these results indicate that
the Gol peptide is retained on the column by virtue of its interaction
with EF-Tu.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 1.
A Gol peptide-S-Tag fusion protein can bind
Sepharose 4B glutathione-immobilized GST-EF-Tu. Extracts were made
of each construct as described under "Experimental Procedures,"
mixed, and applied to a Sepharose 4B glutathione column, and bound
material was eluted with glutathione. For each experiment, lane
a represents the applied extracts, lane b, the column
flow-through, and lanes c-e, f, or g
the first three, four, or five fractions eluted from the column. The
results for the detection of the S-Tag using an S-Tag-specific binding
assay are shown below each lane. A, S-Tag-Gol peptide fusion
extract mixed with GST-EF-Tu fusion extract. A significant amount of
S-Tag signal is observed in the dot blot. B and
C, control experiments in which GST-EF-Tu was mixed with the
S-Tag peptide (no Gol control) and GST was mixed with S-Tag-Gol peptide
(no EF-Tu control) prior to their application to the column. In both
cases, little or no S-Tag is retained, indicating the need for both
EF-Tu and the Gol sequence for interaction on the column.
|
|
Attempts were made to recapitulate these chromatographic experiments
using the chemically synthesized 29-residue Gol peptide. However, we
were unable to detect retention of EF-Tu on a Gol peptide affinity
column nor indeed retention of the peptide to an EF-Tu affinity column
(data not shown). It is clear from estimates of the binding constant
for the Gol peptide-EF-Tu complex (see below) that the synthetic
peptide binds weakly to EF-Tu, which explains why complexes could not
be detected chromatographically using the peptide. The fact that
binding could be detected for the 60-mer version of the Gol peptide in
the GST and S-Tag experiments implies that the extra flanking amino
acids from gp23 likely increase the binding affinity for EF-Tu. Lastly,
we could not detect Lit retention on the EF-Tu or Gol-peptide affinity
columns. This implied that binary complexes between Lit and the other
components did not occur or were too weak to be
detected.2
The Gol Peptide-EF-Tu Complex Is the Substrate for Lit
Cleavage--
The chromatographic experiments suggested that the Gol
peptide formed a complex with EF-Tu. However, these experiments did not
address the question of whether the resulting complex is relevant to
the mechanism by which the Gol peptide activates proteolysis of EF-Tu
by Lit. To investigate this, we employed chemical cross-linking, which
is capable of capturing even weakly bound complexes, and, to simplify
interpretation, we focused on the chemically synthesized Gol peptide
and purified EF-Tu. Using the bifunctional, zero-length cross-linking
reagent EDC, it was possible to specifically cross-link the synthetic
29-residue Gol peptide to EF-Tu bound with GDP (Fig. 2, lane 1) demonstrating that
a complex is detectable. A cross-linked adduct was observed of ~47
kDa, corresponding to EF-Tu (44 kDa) covalently bound with a single
copy of the 3-kDa Gol peptide (cross-linking efficiency ~20% by
laser densitometry). Increasing concentrations of either the
cross-linking reagent or Gol peptide did not yield species of higher
molecular mass (data not shown), suggesting that a 1:1 complex was
being cross-linked. Cross-linking was also used to probe for Gol
peptide binding to Lit, but no cross-linked adducts could be detected
(data not shown).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 2.
The Gol peptide-EF-Tu cross-linked complex is
a substrate for Lit cleavage. The cross-linking and cleavage
reactions were set-up as described under "Experimental Procedures,"
and 2- to 3-µg samples were analyzed by 10% SDS-PAGE. Lane
1, EF-Tu·GDP (2 µM) and Gol peptide (200 µM) incubated with EDC (2.5 mM) at 18 °C
for 60 min. Lane 2, Lit protease, at a final concentration
of 2 µM, was added to the cross-linked material in
lane 1 from which excess Gol peptide had been removed.
Lane 3, the addition of excess Gol peptide (5 µM) to the sample in lane 2 showing that
native, uncross-linked EF-Tu is still a substrate for Lit. The
arrows show the changes in mobility of the Gol cross-linked
and native EF-Tu following their cleavage by Lit. The additional band
running at ~24 kDa (highlighted with black
dots) in lanes 2 and 3 are contaminants
derived from the Lit preparation. M refers to molecular mass
markers.
|
|
Having demonstrated cross-linking between EF-Tu and the Gol peptide,
the functional relevance of this complex could then be tested by
incubating the mixture of cross-linked and uncross-linked EF-Tu with
the Lit protease after excess peptide had been removed by
gel-filtration chromatography (see "Experimental Procedures"). Only
the EF-Tu to which the Gol peptide was covalently attached was a
substrate for Lit cleavage as deduced by the loss of the upper band at
47 kDa but not the lower band at 44 kDa (Fig. 2, lane 2).
The specific cleavage of cross-linked EF-Tu is also apparent from the
size of the cleavage fragments. Lit-mediated proteolysis of native
EF-Tu ordinarily yields two cleavage fragments of approximately 37 kDa
(amino acids 60-393) and 7 kDa (amino acids 1-59), respectively, with
only the larger fragment being visible on 10% SDS-polyacrylamide gels.
Proteolysis of the cross-linked complex, however, gave rise to a larger
cleavage fragment of ~40 kDa, corresponding to the 37-kDa fragment
covalently bound to the Gol peptide. These results not only demonstrate
the high specificity of cross-linking between the Gol peptide and
EF-Tu, because the complex still acts as a substrate for Lit
proteolysis, but also shows that the cross-linking between Gol peptide
and EF-Tu is to amino acids C-terminal to the cleavage site
(Gly59-Ile60). To demonstrate that EDC does not
inactivate the remaining native EF-Tu, excess Gol peptide was added
along with Lit. Then the uncross-linked EF-Tu was also digested,
generating the normal 37-kDa fragment in addition to the 40-kDa
cross-linked fragment (Fig. 2, lane 3).
Gol Peptide Contacts Domains II and III of EF-Tu--
Because the
Gol peptide is specifically cross-linked to EF-Tu at a site where it
can activate cleavage by Lit, mapping the sites of cross-linking on
EF-Tu should begin to reveal where the Gol peptide binds. We therefore
identified the positions of some of the cross-links by peptide mapping
(see "Experimental Procedures"). These experiments capitalized on
two observations. First, it was possible to specifically radiolabel the
Gol peptide at its single cysteine residue (Cys19) by
chemical modification using tritiated N-ethylmaleimide
([3H]NEM). This modification did not inhibit the ability
of Gol to activate Lit-mediated cleavage of EF-Tu nor its cross-linking with EF-Tu (data not shown), in agreement with our previous data on the
ability of a Cys19
Ala mutant of the Gol peptide to
sustain Lit cleavage of EF-Tu (12). Second, radioactive Gol peptide
cross-linked to EF-Tu was not degraded by trypsin, which allowed the
isolation of EF-Tu peptide fragments that retained Gol-associated
radioactivity. The Gol peptide contains two arginines (at positions 8 and 9 in the 29-residue peptide; see "Experimental Procedures")
both of which are readily digested by trypsin in the unbound peptide. However, no tryptic fragments corresponding to cleaved Gol peptide were
observed for [3H]Gol cross-linked to EF-Tu, implying
protection of the peptide proteolysis sites when bound to the
translation factor (data not shown).
Following cross-linking of [3H]Gol to EF-Tu by EDC and
the removal of excess peptide by gel-filtration, the pooled and
concentrated [3H]Gol peptide-EF-Tu cross-linked complex
was digested with trypsin and fractionated on a reverse-phase C8 column
developed with an acetonitrile gradient (described under
"Experimental Procedures"). Peptides eluted between 5 and 30 min,
with three distinct radioactive pools eluting at 16.5, 18.5, and 20 min
(designated pools A-C, respectively) with little starting material
remaining. The three pools were subjected to further purification on a
reverse-phase C18 column and these data are shown in Fig.
3 (A-C). Homogeneous radiolabeled peptide fractions were isolated from each of these pools
(S1 from pool A, S2 and S3 from pool B, and S4 and S5 from pool C) and
were subjected to N-terminal sequencing during which the eluted
radioactivity was monitored after each cycle.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 3.
Peptide mapping of
[3H]Gol-EF-Tu cross-links. Purified
[3H]Gol-EF-Tu cross-linked complex (~4.5 nmol) was
digested with 2% trypsin and fractionated on a C8 reverse-phase HPLC
column (see "Experimental Procedures"). Three radioactive pools (A,
B, and C), eluting at 16.5, 18.5, and 20 min, respectively, were
collected. The figure shows the subsequent separations of each of these
pools rechromatographed on a C18 reverse-phase column developed using
an acetonitrile gradient, as described under "Experimental
Procedures." Fractions containing 3H-label are indicated
by the shaded boxes, and the cpm values represent background
subtracted counts per fraction. Single radioactive peptides were
collected from these traces (S1, S2,
S3, S4, and S5) and submitted for
N-terminal sequencing. The traces were run at 18 °C while
the absorbance was monitored at 220nm.
|
|
Of the purified peptide fractions from the C18 column, S2 and S5 did
not yield clear data and so were not studied further; S2 contained
trypsin sequence as well as an unassigned sequence, whereas S5 gave
multiple amino acids during each sequencing cycle that could not be
assigned to EF-Tu, trypsin, or the Gol peptide. In both cases the
radioactivity associated with the peptide eluted throughout all the
sequencing cycles.
Interpretable sequencing data were obtained for the remaining three
peptides S1, S3, and S4, and these data are shown in Table I. Peptide fraction S1, isolated in three
independent experiments, corresponded to residues 326-333 of E. coli EF-Tu from domain III, but no discernible Gol sequence could
be identified. The radioactivity associated with each sequencing cycle
of this peptide was only just above background (normally ~25 cpm) and
eluted across all the residues, making sequence-specific assignment of
the cross-linking site impossible. In contrast, peptide S3 was derived
from residues 254-261 of domain II and contained a single unassigned
residue (Cys256), which also corresponded to the elution
position of the radioactivity (Table I). The absence of Gol peptide
sequence infers that, although Gol is bound (because radioactivity is
retained), its N terminus is most likely blocked. Peptide S4 contained
sequence corresponding to both EF-Tu (residues 271-278 of domain II)
and Gol peptide (residues 1-3). After three cycles, however, the Gol
sequence was lost and this corresponded to the appearance of a single
unassigned residue in the EF-Tu sequence (Glu273) and the
elution of all the associated radioactivity (Table I). The data
indicate that Cys256 and Glu273 of domain II
are sites of Gol-peptide cross-linking (both are consistent with the
known chemistry of EDC) as well as residues 326-333 of domain III,
although no single residue can be identified in this domain. It is
important to note that the three identified sequences all lie
C-terminal to the Lit cleavage site at
Gly59-Ile60, consistent with the original
cross-linking data in Fig. 2.
Gol Peptide Inhibits the Intrinsic GTPase of EF-Tu--
EF-Tu is a
member of the GTPase family of proteins, and this enzymatic activity is
central to its role as a translation factor. Consequently, molecules
that affect its properties as a translation factor generally also
affect its GTPase activity (25, 26). Because the Gol peptide binds
EF-Tu, we analyzed its effect upon the intrinsic GTPase activity of
EF-Tu. The inset to Fig. 4
shows that in the presence of 500 µM Gol peptide the
GTPase activity of EF-Tu is inhibited by >50%. Control experiments
with 500 µM bovine serum albumin or unrelated peptides
did not inhibit the GTPase activity, showing that the effect induced by
the Gol peptide was specific (data not shown). Fig. 4 also shows that
this inhibition is dependent upon the concentration of Gol peptide and
saturates at a concentration of >600 µM. From these data
it was possible to estimate a Ki value of ~300
µM, demonstrating a weak interaction between the
29-residue synthetic Gol peptide and EF-Tu, although as indicated
previously this interaction may be stronger in the intact gp23 of the
T4 phage.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
The Gol peptide inhibits the intrinsic GTPase
activity of EF-Tu. Inset, the rates of GTP-hydrolysis
by EF-Tu in the absence ( ) and presence ( ) of 500 µM Gol peptide. The mean observed rates fitting a number
of data sets for each (n = 3) were 6.1 ± 0.2 and
2.5 ± 0.1 fmol of GTP hydrolyzed/pmol of EF-Tu/min, respectively.
The figure also shows the effect of increasing the concentration of the
Gol peptide upon the GTPase activity of EF-Tu. Fitting a number of data
sets (n = 3) to a 1 site ligand binding curve gave a
Ki of ~300 µM (standard
deviation ± 28).
|
|
EF-Tu·GDP is the Preferred Conformer for Lit Proteolysis--
In
the absence of other effector molecules, EF-Tu exists in two distinct
conformations that are determined by the identity of bound nucleotide,
GDP or GTP. Although structural data for E. coli EF-Tu have
been published for both forms, only data for thermophilic EF-Tu factors
(which share a high degree of sequence identity with the E. coli protein) are available in the structure data bases (27, 28)
(Fig. 5). The GDP-bound form of the
protein adopts an "open" conformation while in the GTP-bound form
(in which the nonhydrolyzable analogue guanosine
5'-O-(
,
-imidotriphosphate (GDPNP) is used) EF-Tu is
more compact with its three domains coming together to form the binding
site for aminoacylated tRNA. The domain rearrangements are linked
directly to the conformational changes that take place around the
nucleotide binding site to accommodate the
-phosphate of the GTP,
and it is within this site that Lit-mediated cleavage occurs (Fig. 5).
Moreover, the accessibility of this cleavage site in response to
nucleotide binding mirrors that of the molecule as a whole with the
Gly59-Ile60 bond exposed in the open GDP-bound
form but sequestered in the "closed" GTP-bound form.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 5.
Location of Gol peptide binding on
EF-Tu relative to the position of the Lit cleavage site. Ribbon
structures of EF-Tu·GDPNP from Thermus thermophilus (27)
and EF-Tu·GDP from T. aquaticus (28) prepared using
Molscript (40). Both structures show the positions of the three
-strands from which peptide fractions S1, S3, and S4 were isolated
(shown in red) and thereby define the Gol peptide binding
site. The conversion of EF-Tu·GTP to EF-Tu·GDP, following the
hydrolysis of bound GTP, causes the Lit cleavage site (in
yellow) and the Gol binding site to become more exposed to
solvent and ~15 Å closer to each other. An E. coli EF-Tu
numbering system has been employed (percentage identity between
T. aquaticus and E. coli EF-Tu is ~72%).
However, it should be noted that Cys256 is
Val266 and Glu273 is Asp284 in
T. aquaticus EF-Tu. The three-domain structure of EF-Tu is
also highlighted in the figure. The gray sphere represents
the bound magnesium ion at the active site along with either GDP or the
nonhydrolyzable analogue of GTP, GDPNP (both are shown in black
ball-and-stick representation).
|
|
To gain further insight into the nature of the EF-Tu substrate for
proteolysis by Lit, we tested the effect of nucleotides on the
Lit-mediated cleavage of EF-Tu. Fig. 6
shows that GDP-bound EF-Tu (EF-Tu·GDP) is cleaved at an approximate
2-fold faster rate than that for the GTP-bound form (EF-Tu·GTP). The
Gol peptide also preferentially cross-linked to the GDP-bound
conformation of EF-Tu (data not shown). These data are consistent with
the structural data on EF-Tu and show that the open conformation of EF-Tu·GDP, in which the Gly59-Ile60 bond is
more exposed, is the preferred conformation for Gol binding and
Lit-mediated cleavage.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 6.
EF-Tu·GDP is the preferred substrate for
Lit-mediated proteolysis. The figure shows plots used to determine
the first-order-rate constants for the cleavage of EF-Tu·GDP ( )
and EF-Tu·GTP ( ) by Lit in the presence of the Gol peptide (see
"Experimental Procedures"). Fitting a number of data sets
(n = 4) for each gave mean observed rates of 0.044 and
0.024 min 1, respectively (S.D., ±0.001 and ±0.002
min 1, respectively).
|
|
 |
DISCUSSION |
T4 Gol Peptide Binding to EF-Tu Targets the Cell for Lit-mediated
Proteolysis--
The function of the Gol peptide from gp23 in the
T4-directed phage exclusion response of E. coli could be to
activate proteolysis either by contributing essential catalytic groups
to Lit, activating the substrate EF-Tu, or both. Circumstantial
evidence suggests that the peptide does not activate the protease
directly. For example, if the peptide furnished essential catalytic
groups for Lit, then it might be expected that some of the originally
identified gol mutations in the gp23 protein would not
support cleavage of EF-Tu, as is the case for active site mutations of
essential catalytic groups in enzymes. However, this is not the case,
because overexpression of Lit renders bacteria susceptible to T4
gol mutants (17) and equivalent Gol mutant peptides in the
in vitro assay can activate the cleavage of EF-Tu at
elevated concentrations (12).
The present work shows for the first time that the Gol peptide binds to
EF-Tu, to a site distinct to that cleaved by the enzyme, to form the
specific substrate for Lit. There is still the formal possibility that
the peptide furnishes amino acids for catalysis in the ternary complex,
but this does not seem likely based on the effects of gol
mutations discussed above. It is also possible that the peptide might
bind to Lit in the absence of EF-Tu, although it has not been possible
to detect stable binary complexes between the Gol peptide and Lit using
column chromatography or chemical cross-linking experiments. The most
plausible mechanism at the present time is that Lit only forms a stable
complex with EF-Tu when the Gol peptide is bound, implying that the
binary, Gol peptide-EF-Tu complex is an "activated" substrate for
Lit. This type of substrate activation mechanism has similarities to
the staphylokinase cofactor in the action of plasmin (29). The protein
cofactor does not affect the geometry of the plasmin-active site but
instead forms an additional docking site for the enhanced presentation
of the plasminogen substrate to the enzyme. In this case, both the
enzyme and the substrate are in contact with the activating cofactor. In a similar manner, Gol peptide bound to EF-Tu could form additional contacts with Lit to enable proteolysis to occur at the
Gly59-Ile60 bond.
We have previously shown that Lit-mediated cleavage of EF-Tu is
specific for the tertiary structure of the translation factor, which,
in the context of the present work, is most likely explained by the
specific contacts that are made between the Gol peptide across two
domains of EF-Tu (Fig. 5). The chemical cross-linking data show that
the Gol peptide contacts domains II (residues 271-278 and 254-261)
and III (residues 326-333) of EF-Tu, and so its binding site likely
extends ~30 Å across this domain-domain interface. (At the present
time we cannot discount the possibility that domain I is also contacted
by Gol, but no cross-links were identified in this domain from three
independent experiments.) Both circular dichroism and NMR spectroscopy
indicate that the isolated 29-residue Gol peptide does not have stable
secondary structure in
solution3 but likely adopts a
defined structure on binding to EF-Tu. Twenty-nine amino acids would be
sufficient to span the domain II-domain III interface either as an
extended strand or even as an
-helix.
High-resolution structural information is available for EF-Tu in both
its nucleotide-bound conformations (EF-Tu·GDPNP and EF-Tu·GDP,
respectively) (Fig. 5). From these crystal structures, it is apparent
that, in the GDP-bound conformation, both the Lit cleavage site
(Gly59-Ile60) and the Gol binding sites are
more solvent accessible. This could explain the preferential binding of
the peptide and the faster rate of cleavage for this form of the
translation factor. The interconversion between the GTP- and GDP-bound
conformations of EF-Tu involves a large intramolecular movement of
domain I (the GTPase domain), such that the distance between domains I and II increases by ~10 Å. This movement not only causes the cleft between the two domains to open but presents the Lit cleavage site at
the base of this cleft close to the now exposed Gol binding site at the
domain II/III interface (15-20 Å). Our data suggest that the Gol
peptide binds preferentially to the open complex of EF-Tu bound with
GDP across this interface placing the peptide in the vicinity of the
cleavage site, thereby creating an additional docking surface for the
Lit protease. Binding to the nucleotide product complex in preference
to the closed substrate complex implies that the Gol peptide should be
an inhibitor of the intrinsic GTPase of EF-Tu, and this is precisely
what is observed (Fig. 4).
The Physiological Function of Gol Peptide Binding to
EF-Tu--
The results presented above make it clear that the Gol
region of the major head protein gp23 of T4 binds to EF-Tu and this targets an infected cell for Lit-mediated cell death. The fact that
this association must occur in bacteria whether or not they contain Lit
implies that it has a physiological role. The interaction as measured
in vitro with the 29-residue peptide is weak
(Ki~0.3 mM) by comparison to other
macromolecular associations such as antibody-antigen interactions
(micromolar to nanomolar), although this affinity may well be higher
for intact gp23. In this context it is interesting to note the relative
concentrations of EF-Tu and gp23 in an infected E. coli
cell. EF-Tu represents 5-10% of total cell protein
(~120,000-240,000 copies, equivalent to a concentration of
~0.1-0.2 mM (30)) and that a similar number of gp23
molecules appear late in T4 infection, with 960 self-associating to
form a single phage head particle (31, 32). Because binding of gp23 to
EF-Tu is localized to a small, 29-residue region of the major coat
protein (as defined in vivo by the original gol
mutants and in vitro by peptide binding), this association
could occur as gp23 is being synthesized, suggesting a possible role in
the assembly of the phage head itself. T4 bacteriophage head assembly is highly complex, involving up to 11 different proteins in the prohead
and requiring both host and phage-encoded chaperones (GroEL and gp31,
respectively) as well as scaffolding proteins (for a review see Black
et al. (33)). With its high cellular concentration and its
ability to bind a specific sequence in gp23, EF-Tu might be acting as
an early chaperone or ancillary scaffolding protein in the assembly process.
EF-1
, the human equivalent of EF-Tu, has been reported to have a
chaperone-like function by binding proteins and targeting them for
degradation by the ubiquitin system, a role for which EF-Tu can
substitute (34). The potential for a chaperone-like role for EF-Tu has
been given further credence by recent in vitro work. EF-Tu
can aid the renaturation of denatured proteins such as citrate
synthase,
-glucosidase, and rhodanase (3, 35); forms stable
complexes with several unfolded proteins such as bovine pancreatic
trypsin inhibitor and carboxymethyl
-lactalbumin; and protects some
proteins from irreversible aggregation (3). We speculate that this
chaperone activity may have been put to use by infecting bacteriophage
in vivo to bind the gol region of gp23.
The fact that EF-Tu is a GTPase is also consistent with a putative
chaperone role in phage head assembly, because the translation factor
can switch between two distinct conformational states. Importantly, the
folding properties of EF-Tu are enhanced in the open GDP-bound
conformation (3), the conformation favored for Gol binding, and the
binding of unfolded proteins inhibit its intrinsic GTPase activity
(35), as does Gol peptide. Therefore, it seems possible that EF-Tu
could have a chaperone-like role early in the synthesis/assembly of T4
simply by binding to the Gol sequence of gp23 in a
nucleotide-dependent manner prior to it being shuttled to
GroEL and gp31 (33).
Viral Protein Interactions with Host Translation Factors--
The
association of EF-1
and the human immunodeficiency virus (HIV) type
1 gag polyprotein was reported recently by Cimarelli and Luban (36),
but although this interaction seems to be essential for viral
replication, its role remains unclear. The HIV-1 gag polyprotein is
processed by an activated viral protease and so directs the formation
and release of nascent virions. These proteolyzed products exhibit
important functions during virion assembly, forming the capsid, the
nucleocapsid, and the matrix of the virion while others, such as p6,
play key roles in the early phases of the viral life cycle (for a
review see Swanstrom and Wills (37)). Two of these domains
(nucleocapsid and matrix) have been shown to interact with EF-1
in
an RNA-dependent manner (36). In sharp contrast to the
interaction between gp23 and bacterial EF-Tu, which occurs at the
domain II/III interface, the interaction between matrix and EF-1
has
been shown to take place with domain I at the N terminus of EF-1
(residues 1-14). Furthermore, this interaction not only inhibits host
protein translation but also directs the incorporation of a truncated
form of EF-1
into the viral membrane. Translational inhibition has
also been reported upon the interaction of the herpes simplex virus
1-infected cell protein 0 and EF-1
(38). In addition to these
interactions, it has been shown that RNA polymerase from vesicular
stomatitis virus specifically associates with EF-1
for its activity
(39), which is analogous to the association of bacterial EF-Tu with the
Q
RNA polymerase (2). Whatever their relationship to Gol binding,
these other studies indicate that peptides other than Gol peptide can
bind to translation factors such as EF-Tu. In view of our data on the
binding of a bacteriophage head protein to EF-Tu and that of Cimarelli
and Luban (36) on the complex formed between HIV-1 capsid proteins with
EF-1
, it is tempting to speculate that viral capsid protein association with host translation factors is the norm rather than the
exception and that this association plays a pivotal role in viral
maturation in prokaryotes and eukaryotes.
 |
ACKNOWLEDGEMENTS |
We thank Toni Georgiou (Norwich) and Barend
Kraal (Leiden) for helpful advice during the course of this work and
Andrea Parmeggiani for the gift of the pGEXtufA plasmid. We also
gratefully acknowledge the technical assistance of Veronica Joseph in
East Lansing.
 |
FOOTNOTES |
*
This work was supported by grants from the National Science
Foundation (to L. S.) and from the Biotechnology and Biological Sciences and Research Council (to C. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence may be addressed: E-mail:
c.kleanthous@uea.ac.uk (C. K.) or snyderl{at}msu.edu (L. S.).
Published, JBC Papers in Press, May 2, 2000, DOI 10.1074/jbc.M002546200
2
R. Bingham and C. Kleanthous, unpublished observations.
3
R. Bingham and C. Kleanthous, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
EF, elongation
factor;
MOPS, 4-morpholinepropanesulfonic acid;
HPLC, high pressure
liquid chromatography;
PAGE, polyacrylamide gel electrophoresis;
GST, glutathione S-transferase;
HIV, human immunodeficiency
virus;
NEM, N-ethylmaleimide;
EDC, 1-ethyl-3-(3-dimethylaminopropyl)carbodi-imide hydrochloride;
GDPNP, guanosine 5'-O-(
,
-imidotriphosphate).
 |
REFERENCES |
| 1.
|
Abel, K.,
and Jurnak, F.
(1996)
Structure
4,
229-238
|
| 2.
|
Blumenthal, T.,
Landers, T. A.,
and Weber, K.
(1972)
Proc. Natl. Acad. Sci. U. S. A.
228,
748-751
|
| 3.
|
Caldas, T. D.,
El Yaagoubi, A.,
and Richarme, G.
(1998)
J. Biol. Chem.
273,
11478-11482
|
| 4.
|
Van Noort, J. M.,
Kraal, B.,
Sinjorgo, K. M.,
Peroon, N. L. M.,
Johanns, E. S. D.,
and Bosch, L.
(1986)
Eur. J. Biochem.
160,
557-561
|
| 5.
|
Lippmann, C.,
Lindschau, C.,
Vijgenboom, E.,
Schroder, W.,
Bosch, L.,
and Erdmann, V. A.
(1993)
J. Biol. Chem.
268,
601-607
|
| 6.
|
Yu, Y.-T. N.,
and Snyder, L.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
802-806
|
| 7.
|
Snyder, L.
(1995)
Mol. Microbiol.
15,
415-420
|
| 8.
|
Yarmolinsky, M.
(1995)
Science
267,
836-837
|
| 9.
|
Vaux, D. L.,
and Korsmeyer, S. J.
(1999)
Cell
96,
245-254
|
| 10.
|
Kao, C.,
Gumbs, E.,
and Snyder, L.
(1987)
J. Bacteriol.
69,
1232-1238
|
| 11.
|
Sprinzl, M.
(1994)
Trends Biochem. Sci.
19,
245-250
|
| 12.
|
Georgiou, T., Yu, Y. T. N.,
Ekunwe, S.,
Buttner, M. J.,
Zuurmond, A. M.,
Kraal, B.,
Kleanthous, C.,
and Snyder, L.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
2891-2895
|
| 13.
|
Champness, W. C.,
and Snyder, L.
(1982)
J. Mol. Biol.
155,
395-407
|
| 14.
|
Monod, C.,
Repoila, F.,
Kutateladze, M.,
Tetart, F.,
and Krisch, H. M.
(1997)
J. Mol. Biol.
267,
237-249
|
| 15.
|
Webster, A.,
Hay, R. T.,
and Kemp, G.
(1993)
Cell
72,
97-104
|
| 16.
|
Boon, K.,
Vijgenboom, E.,
Madsen, L. V.,
Talens, A.,
Kraal, B.,
and Bosch, L.
(1992)
Eur. J. Biochem.
210,
177-183
|
| 17.
|
Bergsland, K. J.,
Kao, C., Yu, Y.-T. N.,
Gulati, R.,
and Snyder, L.
(1990)
J. Mol. Biol.
213,
477-494
|
| 18.
|
Cetin, R.,
Anborgh, P. H.,
Cool, R. H.,
and Parmeggiani, A.
(1998)
Biochemistry
37,
486-495
|
| 19.
|
Riddles, P. W.,
Blackeley, R. L.,
and Zerner, B.
(1979)
Anal. Biochem.
94,
75-81
|
| 20.
|
Wittinghofer, A.,
Frank, R.,
and Leberman, R.
(1980)
Eur. J. Biochem.
108,
423-431
|
| 21.
|
Arai, K.-I.,
Nakamura, S.,
Arai, T.,
Kawakita, M.,
and Kaziro, Y.
(1975)
J. Biochem.
79,
69-83
|
| 22.
|
Fasano, O.,
Bruns, W.,
Crechet, J. B.,
Sander, G.,
and Parmeggiani, A.
(1978)
Eur. J. Biochem.
89,
557-565
|
| 23.
|
Mesters, J. R.,
Zeef, L. A. H.,
Hilgenfeld, R.,
de Graaf, J. M.,
Kraal, B.,
and Bosch, L.
(1994)
EMBO J.
13,
4877-4885
|
| 24.
|
Shacter, E.
(1984)
Anal. Biochem.
138,
416-420
|
| 25.
|
Wolf, H.,
Chinali, G.,
and Parmeggiani, A.
(1974)
Proc. Natl. Acad. Sci. U. S. A.
71,
4910-4914
|
| 26.
|
Pingoud, A.,
Block, W.,
Urbanke, C.,
and Wolf, H.
(1982)
Eur. J. Biochem.
123,
261-265
|
| 27.
|
Berchtold, H.,
Reshetnikova, L.,
Reiser, C. O. A.,
Schirmer, N. K.,
Sprinzl, M.,
and Hilgenfeld, R.
(1993)
Nature
365,
126-132
|
| 28.
|
Polekhina, G.,
Thirup, S.,
Kjeldgaard, M.,
Nissen, P.,
Lippmann, C.,
and Nyborg, J.
(1996)
Structure
4,
1141-1151
|
| 29.
|
Parry, M. A. A.,
Fernandez-Catalan, C.,
Bergner, A.,
Huber, R.,
Hopfner, K.-P.,
Scholott, B.,
Guhrs, K.-H.,
and Bode, W.
(1998)
Nat. Struct. Biol.
5,
917-923
|
| 30.
|
Neidhardt, F. C.,
Ingraham, J. L.,
and Schaechter, M.
(1990)
Physiology of the Bacterial Cell
, Sunderland, MA
|
| 31.
|
Baschong, W.,
Aebi, U.,
Baschong-Presianotto, C.,
Dobochet, J.,
Landmann, L.,
Kellenberger, E.,
and Wurtz, M.
(1988)
J. Ultrastruct. Mol. Struct. Res.
99,
189-202
|
| 32.
|
Georgopoulos, C. P.,
and Linder, C. H.
(1994)
in
Molecular Biology of Bacteriophage T4
(Karam, J. D., ed)
, pp. 213-218, ASM Press, Washington, D. C.
|
| 33.
|
Black, L. W.,
Showe, M. K.,
and Steven, A. C.
(1994)
in
Molecular Biology of Bacteriophage T4
(Karam, J. D., ed)
, pp. 218-258, ASM Press, Washington, D. C.
|
| 34.
|
Gonen, H.,
Smith, C. E.,
Siegel, N. R.,
Kahana, C.,
Merrick, W. C.,
Chakraburtty, K.,
Scwartz, A. L.,
and Ciechanover, A.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
7648-7652
|
| 35.
|
Kudlicki, W.,
Coffman, A.,
Kramer, G.,
and Hardesy, B.
(1997)
J. Biol. Chem.
272,
32206-32210
|
| 36.
|
Cimarelli, A.,
and Luban, J.
(1999)
J. Virol.
73,
5388-5401
|
| 37.
|
Swanstrom, R.,
and Wills, J. W.
(1997)
in
Retroviruses
(Coffin, J. M.
, Hughes, S. H.
, and Varmus, H. E., eds)
, pp. 263-334, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 38.
|
Kawaguchi, Y.,
Bruni, R.,
and Roizman, B.
(1997)
J. Virol.
71,
1019-1024
|
| 39.
|
Das, T.,
Mather, M.,
Gupta, A. K.,
Janssen, G. M. C.,
and Banerjee, A. K.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
1449-1454
|
| 40.
|
Kraulis, P. J.
(1991)
J. Appl. Crystallogr.
24,
946-950
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Zhou, J. Liu, Q. Wang, X. Liu, X. Li, P. Li, Q. Ma, and C. Cao
The Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus Inhibits Cell Cytokinesis and Proliferation by Interacting with Translation Elongation Factor 1{alpha}
J. Virol.,
July 15, 2008;
82(14):
6962 - 6971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Copeland and C. Kleanthous
The Role of an Activating Peptide in Protease-mediated Suicide of Escherichia coli K12
J. Biol. Chem.,
January 7, 2005;
280(1):
112 - 117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Miller, E. Kutter, G. Mosig, F. Arisaka, T. Kunisawa, and W. Ruger
Bacteriophage T4 Genome
Microbiol. Mol. Biol. Rev.,
March 1, 2003;
67(1):
86 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|